Astal Laboratories Limited (BSE: 512600)
Health Care · Pharmaceuticals · IN
Rs68.14
-2.01% today · -30.3% 1Y
Astal Laboratories Limited (BSE: 512600) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $30.84M.
Over the last twelve months the share price has lost 30.3%, trading between 60.45 and 103.00.
Tweenvest scores Astal Laboratories Limited across four factors: quality 47/100, value 66/100. Its strongest factor is value.
512600 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.84M
- Revenue (TTM)
- $34.07M
- P/E
- 12.96
- EPS
- 5.26
- Dividend yield
- —
- Beta (5Y)
- -0.45
- 52-week high
- Rs103.00
- 52-week low
- Rs60.45
- Avg volume (3M)
- —
- Shares outstanding
- 43.80M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
| MIRA Pharmaceuticals, Inc.NasdaqCM: MIRA | $31.33M | $0.70 | -6.60% |
| BioNxt Solutions Inc.CNSX: BNXT | $31.00M | CA$0.33 | -14.47% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $— | — |
| Aarey Drugs & Pharmaceuticals LimitedBSE: 524412 | $30.64M | Rs104.20 | +1.12% |
| Eagle Veterinary Technology Co.,LtdKOSDAQ: A044960 | $29.95M | ₩3,185.00 | +3.41% |
| Sabaa International Company for Pharmaceutical and Chemical IndustryCASE: SIPC | $29.60M | EGP6.20 | +20.86% |
Figures last refreshed Oct 11, 2026.